Novartis India Overview
- Year Founded
-
1947
- Status
-
Public
- Employees
-
62
- Stock Symbol
-
500672
- Share Price
-
$10.01
- (As of Wednesday Closing)
Novartis India General Information
Description
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment namely Pharmaceutical Business, Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.
Contact Information
Website
www.novartis.inCorporate Office
- Inspire BKC
- 7th Floor, Bandra-Kurla Complex, Bandra (East)
- Mumbai, Maharashtra 400051
- India
Corporate Office
- Inspire BKC
- 7th Floor, Bandra-Kurla Complex, Bandra (East)
- Mumbai, Maharashtra 400051
- India
Novartis India Stock Performance
As of 22-Jan-2025, Novartis India’s stock price is $10.01. Its current market cap is $247M with 24.7M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.01 | $9.92 | $9.62 - $14.92 | $247M | 24.7M | 6.58K | $0.42 |
Novartis India Financials Summary
As of 30-Sep-2024, Novartis India has a trailing 12-month revenue of $41.3M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| EV | 260,762 | 245,318 | 102,116 | 128,817 |
| Revenue | 41,268 | 40,350 | 45,968 | 52,018 |
| EBITDA | 8,477 | 8,649 | 8,554 | (1,419) |
| Net Income | 10,483 | 10,290 | 12,872 | (499) |
| Total Assets | 106,419 | 110,912 | 119,723 | 126,281 |
| Total Debt | 720 | 836 | 2,620 | 3,166 |
Novartis India Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Novartis India Comparisons
Industry
Financing
Details
Novartis India Competitors (11)
One of Novartis India’s 11 competitors is Takeda Pharmaceutical Company, a Corporation company based in Tokyo, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Company | Corporation | Tokyo, Japan | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom | ||||
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Alkem Laboratories | Formerly PE-Backed | Mumbai, India |
Novartis India Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Novartis India Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Novartis India ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Novartis India FAQs
-
When was Novartis India founded?
Novartis India was founded in 1947.
-
Where is Novartis India headquartered?
Novartis India is headquartered in Mumbai, India.
-
What is the size of Novartis India?
Novartis India has 62 total employees.
-
What industry is Novartis India in?
Novartis India’s primary industry is Pharmaceuticals.
-
Is Novartis India a private or public company?
Novartis India is a Public company.
-
What is Novartis India’s stock symbol?
The ticker symbol for Novartis India is 500672.
-
What is the current stock price of Novartis India?
As of 22-Jan-2025 the stock price of Novartis India is $10.01.
-
What is the current market cap of Novartis India?
The current market capitalization of Novartis India is $247M.
-
What is Novartis India’s current revenue?
The trailing twelve month revenue for Novartis India is $41.3M.
-
Who are Novartis India’s competitors?
Takeda Pharmaceutical Company, Zydus Lifesciences, AstraZeneca, Sun Pharmaceutical Industries, and Alkem Laboratories are some of the 11 competitors of Novartis India.
-
What is Novartis India’s annual earnings per share (EPS)?
Novartis India’s EPS for 12 months was $0.42.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
